About Chad Costley
Form D filings for BlueWillow Biologics from 2017 to 2024 list Chad Costley as president & chief executive officer, director.
Chad Costley first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Chad Costley in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Chad Costley works with at each company, as listed on that company's latest Form D.
BlueWillow Biologics, Inc. · Form D, Feb 12, 2024
PW
Phil Wilmington
Director
DS
David Stout
Director
RO
Roger D'Orazio
Director
GA
George Arida
Executive officer
HB
Hugo Braun
Director